[HTML][HTML] The heart and COVID-19: what cardiologists need to know
IBSS Costa, CS Bittar, SI Rizk… - Arquivos brasileiros de …, 2020 - SciELO Brasil
Frente à pandemia da doença causada pelo novo coronavírus (COVID-19), o manejo do
paciente com fator de risco e/ou doença cardiovascular é desafiador nos dias de hoje. As …
paciente com fator de risco e/ou doença cardiovascular é desafiador nos dias de hoje. As …
Viral myocarditis—incidence, diagnosis and management
M Olejniczak, M Schwartz, E Webber, A Shaffer… - Journal of cardiothoracic …, 2020 - Elsevier
Viral myocarditis has an incidence rate of 10 to 22 per 100,000 individuals. The presentation
pattern of viral myocarditis can range from nonspecific symptoms of fatigue and shortness of …
pattern of viral myocarditis can range from nonspecific symptoms of fatigue and shortness of …
[HTML][HTML] O Coração ea COVID-19: O que o Cardiologista Precisa Saber
IBSS Costa, CS Bittar, SI Rizk… - Arquivos Brasileiros …, 2020 - SciELO Brasil
Frente à pandemia da doença causada pelo novo coronavírus (COVID-19), o manejo do
paciente com fator de risco e/ou doença cardiovascular é desafiador nos dias de hoje. As …
paciente com fator de risco e/ou doença cardiovascular é desafiador nos dias de hoje. As …
Chinese society of cardiology expert consensus statement on the diagnosis and treatment of adult fulminant myocarditis
D Wang, S Li, J Jiang, J Yan, C Zhao, Y Wang… - Science China Life …, 2019 - Springer
Fulminant myocarditis is primarily caused by infection with any number of a variety of
viruses. It arises quickly, progresses rapidly, and may lead to severe heart failure or …
viruses. It arises quickly, progresses rapidly, and may lead to severe heart failure or …
Patients with fulminant myocarditis supported with veno-arterial extracorporeal membrane oxygenation: a systematic review and meta-analysis of short-term mortality …
JKK Vishram-Nielsen, F Foroutan, S Rizwan… - Heart Failure …, 2023 - Springer
Fulminant myocarditis (FM) may lead to cardiogenic shock requiring veno-arterial
extracorporeal membrane oxygenation (VA-ECMO). Results of effectiveness studies of VA …
extracorporeal membrane oxygenation (VA-ECMO). Results of effectiveness studies of VA …
[HTML][HTML] Clinical complications during veno-arterial extracorporeal membrane oxigenation in post-cardiotomy and non post-cardiotomy shock: still the achille's heel
Extracorporeal membrane oxygenation (ECMO) is life-saving for potentially reversible heart
failure and respiratory injuries not responsive to conventional therapies. Technological …
failure and respiratory injuries not responsive to conventional therapies. Technological …
outcomes with peripheral venoarterial extracorporeal membrane oxygenation for suspected acute myocarditis: 10-year experience from the Extracorporeal Life …
JI Nunez, EW Grandin, T Reyes-Castro… - Circulation: Heart …, 2023 - Am Heart Assoc
BACKGROUND: Acute myocarditis can result in severe hemodynamic compromise requiring
venoarterial extracorporeal membrane oxygenation (VA-ECMO). Outcomes and factors …
venoarterial extracorporeal membrane oxygenation (VA-ECMO). Outcomes and factors …
Intraoperative management of adult patients on extracorporeal membrane oxygenation: An expert consensus statement From the Society of Cardiovascular …
MA Mazzeffi, VK Rao, J Dodd-o, JM Del Rio… - Anesthesia & …, 2021 - journals.lww.com
In the second part of the Society of Cardiovascular Anesthesiologists Extracorporeal
Membrane Oxygenation (ECMO) working group expert consensus statement, venoarterial …
Membrane Oxygenation (ECMO) working group expert consensus statement, venoarterial …
Can VA-ECMO be used as an adequate treatment in massive pulmonary embolism?
R Giraud, M Laurencet, B Assouline… - Journal of Clinical …, 2021 - mdpi.com
Introduction: Massive acute pulmonary embolism (MAPE) with obstructive cardiogenic shock
is associated with a mortality rate of more than 50%. Venoarterial extracorporeal membrane …
is associated with a mortality rate of more than 50%. Venoarterial extracorporeal membrane …
Extracorporeal membrane oxygenation support in 2019 novel coronavirus disease: indications, timing, and implementation
M Li, SC Gu, XJ Wu, JG Xia, Y Zhang… - Chinese Medical …, 2020 - mednexus.org
The 2019 novel coronavirus disease (COVID-19) has spread rapidly across Hubei province
and to all regions in China owing to its person-to-person transmission and strong …
and to all regions in China owing to its person-to-person transmission and strong …